Use of gaboxadol, ganaxolone and allopregnanolone to treat movement disorders
OwnerMatthew DURINGinventor
Life of this patent
Estimating the term…
Abstract
Use of gaboxadol, allopregnanolone, or ganaxolone, or a pharmaceutical salt of any of the foregoing, for the treatment of cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, or dystonia in a subject in need thereof.
Claims20
A method of treating a movement disorder selected from the group consisting of cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, and dystonia, comprising administering to a patient in need thereof about 0.05 mg to about 30 mg gaboxadol or a pharmaceutically acceptable salt thereof, wherein the method provides improvement in one or more symptoms of the cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, or dystonia in the patient.
A method of treating a movement disorder selected from the group consisting of cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, or dystonia, comprising administering to a patient in need thereof about 0.01 mg to about 20 mg allopregnanolone or a pharmaceutically acceptable salt thereof, wherein the method provides improvement in one or more symptoms of the cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, or dystonia in the patient.
A method of treating a movement disorder selected from the group consisting of cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, or dystonia, comprising administering to a patient in need thereof about 5 mg to about 2000 mg ganaxolone or a pharmaceutically acceptable salt thereof, wherein the method provides improvement in one or more symptoms of the cervical dystonia, multiple system atrophy, myoclonus, progressive supranuclear palsy, restless legs syndrome, Wilson's disease, ataxia, chorea, or dystonia in the patient.
Dependencies are inferred from the claim text.